Table 2 Baseline characteristics of inoperable and irresectable patients

N = 127

33

94

Sex

0.21

Male n (%)

20 (61%)

68 (72%)

Female n (%)

13 (39%)

26 (28%)

Age (years) (mean and SD)

72 (9)

63 (10)

0.00

Range

53-89

25-84

BMI (kg/m2) (mean and SD)

24.1 (5.4)

23.6 (3.6)

0.65

BSA (m2) (mean and SD)

2.0 (0.6)

1.8 (0.2)

0.16

Tumor length (cm) (mean and SD)

5.2 (2.7)

6.5 (2.7)

0.04

Stage I/II

13 (40.6%)

n.a.

Stage III/IV

19 (59.4%)

100%

Missing

1

Histology

0.14

Adenocarcinoma

18 (55%)

35 (37%)

Squamous cell car.

12 (36%)

53 (56%)

NNO

3 (9%)

6 (6%)

Laboratory

Creatinine μmol/l (median and IQR)

79 (64–105)

70 (60–82)

0.03

Albumin U/l (mean and SD)

43 (4)

43 (4)

0.99

Hemoglobin mmol/l (mean and SD)

8.6 (1.0)

8.4 (1.0)

0.38